Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Tox21_300395

Client Email

Product

Tox21_300395
US Patents

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Tox21_300395

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 10 USDMF, 12 CEP/COS, 2 JDMF, 6 EU WC, 2 KDMF, 8 NDC API, 24 Listed Suppliers, $ API Reference Price

33 API Suppliers
10 USDMF
12 CEP/COS
2 JDMF
6 EU WC
2 KDMF
8 NDC API
24 Listed Suppliers
$ API Reference Price

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

17 API Suppliers

17 API Suppliers

FINISHED DOSAGE FORMULATIONS

147 FDF Dossiers, 49 FDA Orange Book, 44 Europe, 15 Canada, 7 Australia, 11 South Africa, 21 Listed Dossiers

147 FDF Dossiers
49 FDA Orange Book
44 Europe
15 Canada
7 Australia
11 South Africa
21 Listed Dossiers

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 1 DKSH, 2 Jai Radhe Sales, 4 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 6 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 BASF, 7 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 26 Kerry, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 21 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem

4 SPI Pharma
1 DKSH
2 Jai Radhe Sales
4 Boai NKY Pharmaceuticals Ltd
13 Gangwal Healthcare
3 Nanjing Well Pharmaceutical
6 Actylis
8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
12 BASF
7 DFE Pharma
1 Finar
9 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
4 Ingredion Pharma Solutions
26 Kerry
14 Microlex e.U
1 Nanjing Bold Chemical
1 Novo Excipients
3 Pharmatrans-Sanaq
6 Pluviaendo
4 Prachin Chemical
21 Roquette
7 Seppic
5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shanghai Welltone Material Technology Co., Ltd
11 Sigachi Industries
2 Ulanqab Kema New Material
4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 34 Direct Compression, 29 Disintegrants & Superdisintegrants, 20 Solubilizers, 19 Granulation, 19 Co-Processed Excipients, 18 Thickeners and Stabilizers, 16 Lubricants & Glidants, 12 Parenteral, 11 Controlled & Modified Release, 9 Coating Systems & Additives, 8 Film Formers & Plasticizers, 7 Taste Masking, 7 Emulsifying Agents, 6 Topical, 5 Chewable & Orodispersible Aids, 3 Rheology Modifiers, 3 API Stability Enhancers, 2 Surfactant & Foaming Agents, 1 Dry Powder Inhalation

72 Fillers, Diluents & Binders
34 Direct Compression
29 Disintegrants & Superdisintegrants
20 Solubilizers
19 Granulation
19 Co-Processed Excipients
18 Thickeners and Stabilizers
16 Lubricants & Glidants
12 Parenteral
11 Controlled & Modified Release
9 Coating Systems & Additives
8 Film Formers & Plasticizers
7 Taste Masking
7 Emulsifying Agents
6 Topical
5 Chewable & Orodispersible Aids
3 Rheology Modifiers
3 API Stability Enhancers
2 Surfactant & Foaming Agents
1 Dry Powder Inhalation

DIGITAL CONTENT

26 NEWS #PharmaBuzz

26 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 47 Finished Drug Prices, 3 Annual Reports

1 US Medicaid Prescriptions
47 Finished Drug Prices
3 Annual Reports

MARKET PLACE

15 APIs, 22 FDF Dossiers

15 APIs
22 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents

3 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 16 Others

3 EDQM
4 USP
16 Others

$ API Ref.Price (USD/KG) : 145 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3BAXTER HLTHCARE

filter Patent Number Reset all filters

3 All

01 37635773

filter API Patent Reset all filters

3 All

01 3Blank

filter FDF Patent Reset all filters

3 All

01 3Y

filter Expiration Date Reset all filters

3 All

01 32029-03-13

Product Main Page

01

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

BAXTER HLTHCARE

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 7635773

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

BAXTER HLTHCARE

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 7635773

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

Formnext Forum

Not Confirmed

BAXTER HLTHCARE

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 7635773

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?